FDA Inspection 1210865 — Regis Peffault De Latour, M.D.
The FDA completed an inspection of Regis Peffault De Latour, M.D. on Jul 13, 2023 in Paris Cedex 10. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 13, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Paris Cedex 10 (France)
Additional details
Clinical Investigator (CI)